hand-foot syndrome, HFS
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with malignant tumor confirmed by pathology or cytology; Patients with grade I or above HFS after receiving chemotherapy or targeted therapy; Karnofsky score>60 points; No serious dysfunction of heart, liver, kidney and other important organs; Estimated survival time>3 months, age 18 - 80 years; Informed consent.
Exclusion criteria
Exclusion criteria: Patients with pre-existing nervous system diseases; patients with rheumatoid arthritis; Patients with diabetes complicated with nervous system diseases; Patients with severe dysfunction of heart, liver, kidney and other important organs; Patients who are receiving other non-chemotherapeutic agents that may cause neurotoxicity; Patients with uncontrolled infections and metabolic diseases; Pregnant or mentally ill.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom Score;Pain Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Score;Blood inflammatory factors; | — |
Countries
China
Contacts
Shenzhen Hospital of Beijing University of Chinese Medicine